(Q61868167)
Statements
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses (English)
Donald W Milligan
Savio Fernandes
Ranjit Dasgupta
Faith E Davies
Estella Matutes
Christopher D Fegan
Christopher McConkey
J Anthony Child
Daniel Catovsky
National Cancer Research Institute Haematological Studies Group